DIMENSIONAL FUND ADVISORS LP

Position in FLNA — Filana Therapeutics, Inc.

CIK 354204 AUSTIN, TX

Position in FLNA

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$405,439

+$128,127 QoQ

Shares Held

239,906

+71.3% QoQ

Ownership

0.497%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 90% Shared 10% None 0%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. FLNA ranks #171 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$405,439	239,906	+71.3%	Shares	Sole	2026-05-07
2025-12-31	$277,312	140,057	+372.3%	Shares	Sole	2026-02-12
2024-03-31	$601,719	29,656	+71.1%	Shares	Sole	2024-05-10
2023-12-31	$390,255	17,337	+178.4%	Shares	Sole	2024-02-07
2022-09-30	$260,413	6,227	+61.5%	Shares	Sole	2022-11-10
2021-09-30	$239,380	3,856	-85.4%	Shares	Sole	2021-11-12
2021-06-30	$2,252,198	26,360	-0.9%	Shares	Defined	2021-08-12
2021-03-31	$1,195,085	26,587	-7.5%	Shares	Defined	2021-05-14
2020-12-31	$196,075	28,750	0.0%	Shares	Defined	2021-03-08
2020-09-30	$330,912	28,750	0.0%	Shares	Defined	2020-11-12
2020-06-30	$88,550	28,750	+118.0%	Shares	Defined	2020-08-13
2020-03-31	$54,194	13,186	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.